Navigation Links
Advanced BioHealing Named to Prestigious Inc. 500 List of America's Fastest Growing Private Companies
Date:8/25/2011

WESTPORT, Conn., Aug. 25, 2011 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH), a leader in commercializing regenerative medicine therapies, today announced that it ranked in the top 200 (No. 187) on this year's Inc. 500 list of America's fastest-growing, privately held companies.

Inc. magazine's annual list provides the most comprehensive look at a vital segment of the U.S. economy—America's independent-minded entrepreneurs. ABH increased revenue from zero in 2006 to $146 million in 2010 and by year-end employed more than 300 professionals. It is this success that led to the recent acquisition of ABH by Shire plc, the global specialty biopharmaceutical company. The acquisition combines ABH's experience and commercial capability in regenerative medicine with Shire's expertise in developing and commercializing products targeting unmet medical needs, and in human cell biological manufacturing.  

"This recognition reflects the hard work and dedication of the extraordinarily talented team here at ABH," said Kevin Rakin, CEO. "Since 2006, we have built a fully integrated, profitable regenerative medicine company marketing Dermagraft, an FDA-approved living cell therapy with a dedicated sales force, scalable cell-based manufacturing, and established reimbursement."

About Advanced BioHealing, Inc.

Advanced BioHealing (ABH), a Shire company, specializes in the development and commercialization of life-altering regenerative medicine therapies. ABH currently manufactures and markets Dermagraft®, a bio-engineered skin substitute approved by the FDA for the treatment of diabetic foot ulcers, that assists in restoring damaged tissue and supports the body's natural healing process. The Company maintains its corporate office in Westport, Conn. with additional sites in La Jolla, Calif. and Nashville, Tenn. To learn more about ABH, please visit the Company's web site at www.ABH.com.

Media Contacts:
Lindsey Hart
Advanced BioHealing
lhart@abh.com
Direct: (615) 250-3311
Cell: (206) 335-0114

Marites Cristobal
Edelman
marites.cristobal@edelman.com
Direct: (323) 202-1424
Cell: (415) 819-2214


'/>"/>
SOURCE Advanced BioHealing, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
2. Advanced Life Sciences Announces Second Quarter 2008 Financial Results
3. LUMEDX Introduces Advanced Multi-Modality, Multi-Vendor, Web-Enabled ECG Management Solution
4. Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance
5. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
6. Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services
7. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
8. Advanced Chemical Transport Opens Merced Facility
9. Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008
10. Advanced Instruments Acquires D & F Control Systems Inc.
11. DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):